Hasil Pencarian :: Kembali

  1. Beranda
  2. Hasil Pencarian
 Pencarian Spesifik
Ditemukan 2410 dokumen yang sesuai dengan query ::  Simpan CSV
cover
Journal of Public Health, Vol.30, No.3, Sept. 2008, hal. 313-321. ( ket. ada di bendel June - Dec. 2008)
[s.l.] : [s.n.] : s.a.]
Indeks Artikel Jurnal-Majalah   Pusat Informasi Kesehatan Masyarakat
☉
cover
The Am. Jour. of Clinical Nutrition ( AJCN ), Vol. 100, No.4, Oct. 2014, hal. 1158-1165
[s.l.] : [s.n.] : s.a.]
Indeks Artikel Jurnal-Majalah   Pusat Informasi Kesehatan Masyarakat
☉
cover
Julia A. Fox-Rushby
612.3 FOX d
London : Office of Health Economics, 2002
Buku (pinjaman 1 minggu)   Pusat Informasi Kesehatan Masyarakat
☉
cover
Latifatul Khoiriyah; Pembimbing: Indang Trihandini; Penguji: Wahyu Septiono, Iqbal Ridzi Fahdri Elyazar
Abstrak:
Latar belakang: Diabetes melitus tipe 2 masih menjadi masalah kesehatan global yang serius. Prevalensi DMT2 selalu meningkat dari tahun 2000-2021 yakni dari 4,55% menjadi 10,6%. Angka kematian DMT2 juga mengalami peningkatan sebanyak 57,94% dari tahun 2011 ke tahun 2021. Walaupun pemerintah sudah berupaya dalam mengendalikan DMT2, beban penyakit ini diproyeksikan meningkat hingga tahun 2045. DMT2 merupakan penyakit dengan angka mortalitas dan morbiditas yang tinggi. Beban penyakit DMT2 ini dapat tercermin dalam ukuran DALYs. Penelitian ini bertujuan untuk melihat tren DALYs penyakit DMT2 dan faktor risikonya di Indonesia tahun 1990-2021. Metode: Penelitian ini menggunakan metode systematic review dengan data sekunder Global Burden of Disease 2021. Populasi dari penelitian ini adalan penduduk usia ≥ 35 tahun di 34 provinsi di Indonesia dengan unit analisis provinsi. Variabel dalam penelitian ini adalah DALYs DMT2, DALYs DMT2 akibat IMT tinggi, dan DALYs DMT2 akibat perilaku merokok. Hasil: Penelitian menjukkan DALYs DMT2 mengalami kenaikan sebesar 59,6% dari tahun 1990-2021. Faktor yang paling berkontribusi dalam DALYs DMT2pada tahun 2021 yaitu IMT tinggi (41,7%) dan perilaku merokok (15,8%). DALYs DMT2 yang disebabkan oleh faktor risiko tersebut juga mengalami kenaikan, dengan rincian 133,21% untuk IMT tinggi dan 69,2% untuk perilaku merokok. Kesimpulan: DALYs DMT2, DALYs DMT2 akibat IMT tinggi, dan DALYs DMT2 akibat perilaku merokok selalu meningkat dari tahun 1990-2021. Hal ini menunjukkan kewaspadaan masyarakat terhadap dampak DMT2 yang masih rendah.
Background: Type 2 diabetes mellitus remains a serious global health problem. The prevalence of T2DM has always increased from 2000-2021, from 4.55% to 10.6%. The mortality rate of T2DM also increased by 57.94% from 2011 to 2021. Despite the government's efforts to control T2DM, the disease burden is projected to increase until 2045. T2DM is a disease with high mortality and morbidity. The disease burden of T2DM can be reflected in the DALYs measure. This study aims to examine the trend of T2DM disease DALYs and its risk factors in Indonesia from 1990 to 2021. Methods: This study used systematic review methods with secondary data from the Global Burden of Disease 2021. The population of this study was the population aged ≥ 35 years in 34 provinces in Indonesia. The variables in this study were T2DM DALYs, T2DM DALYs due to high BMI, and T2DM DALYs due to smoking behaviour. Results: The study showed that T2DM DALYs increased by 59.6% from 1990-2021. The most contributing factors to T2DM DALYs in 2021 were high BMI (41.7%) and smoking behaviour (15.8%). T2DM DALYs caused by these risk factors also increased, with 133.21% for high BMI and 69.2% for smoking behaviour. Conclusion: T2DM DALYs, T2DM DALYs due to high BMI, and T2DM DALYs due to smoking behaviour always increased from 1990-2021. This shows that public awareness of the impact of T2DM is still low.
Read More
S-11583
Depok : FKM-UI, 2024
S1 - Skripsi   Pusat Informasi Kesehatan Masyarakat
☉
cover
Bulletin of the WHO, Vol.92, Iss.3, March 2014, hal. 226-228
[s.l.] : [s.n.] : s.a.]
Indeks Artikel Jurnal-Majalah   Pusat Informasi Kesehatan Masyarakat
☉
cover
Workshop on eviden for health policy: burden of disease, cost-effectiveness, and health systems. (Daftar isi: 1. Model of mortality and age composition; 2. Life tables for 191 countries: data methods and results, A.D. Lopez (et al); 3. WHO system of model life tables, C.J.L. Murray (et al); 4. Measuring mortality, fertility, and natural increase: a self teaching guide elementary measures, James A. Palmore; 5. MortPak-life: the United Nations software package for mortality measurement; 6. Measuring the health of the U.S. population, David M. Cutler; 7. Summarizing population health: directions for the development and application of population metrics; 8. A critical examination of summary measures of population health, Christopher J.L. Murray (et al); 9. Health status assessment methods for adults: past accomplishments and future challenges, Colleen A. McHorney; 10. Comparative analysis more than 50 household surveys on health status, Ritu Sadana (et al); 11. Health expectancy: an indicator for change ?, Jan J. Barendregt (et al); 12. Health expectancies: an overview and critical appraisal, Colin Mathers; 13. Estimates of dale for 191 countries: methods and results, Colin D. Mathers (et al); 14. Active life among the elderly in the United States: multistate life-table estimates and population projections, Richard G. Rogers; 15. Premature mortality in the United States: public health issues in the use of years of potential life lost; 16. Decline in tuberculosis: the death rate falls to tell entire story, Mary Dempsey; 17. Aging, natural death, and the compression of morbidity, James F. Fries; 18. A standardized rate for mortality defined in units of lost years of life, William Haenszel; 18. Measuring the burden of disease: healthy life-years, Adnan A. Hyder; 19. Applying burden of disease methods in developing countries: a case study from Pakistan, Adnan A Hyder; 20. Past and future life expectancy increases at later ages: thrie implications for the linkage of chronic morbidity, disability, and mortality, Kenneth G. Manton; 21. Premature death in the United States: years of life lost and health priorities, Janet D. Perloff (et al); 22. Use of direct and indirect techniques for estimating the completeness of death registration systems, Samuel H. Preston; 23. Approaches to the collection of mortality data in the context of data needs; 24. Age patterns of marriage, Ansley J. Coale; 25. Factors influincing discrepancies between premortem and postmortem diagnoses, Ron M. Battle (et al); 26. Diagnostic errors discovered at autopsy, Mona Britton; 27. Verbal autopsies for adult deaths: issues in their development and validation, Daniel C. (et al); 28. Elements for a theory of the health transition, Julio F. (et al); 29. Analytical potential for multiple cause-of-death data, Robert A. Israel; 30. Death certificate coding practices related to diabetes in European countries - the 'EURODIAB subarea C' study, Eric J. (et al); 31. The Epidemiologic transition: a theory of the epidemiology of population change, Abdel R. Omran; 32. Childhood deaths in Africa: use and limitations of verbal autopsies; 33. Maternal recall of symptoms associated with childhood deaths in rural East Africa, RW Snow, (et al); 34. An appraisal of the epidemic rise of coronary heart disease and its decline, W.E. stehbens; 35. Measurement of overall and causes-specific mortality in infants and children: memorandum from a WHO/UNICEF meeting)
P 362.1 WOR w
[s.l.] : Geneva: WHO, 2000, s.a.]
Prosiding   Pusat Informasi Kesehatan Masyarakat
☉
cover
Workshop on evidence for health policy: burden of disease, cost-effectiveness, and health systems. (Daftar isi: 1. Compositional models for mortality by age, sex and cause, Joshua A Salomon; 2. The epidemiological transitional: policy and planning implications for developing countries, James N. Gribble; 3. Methodology for measuring health-state preferences - 1: measurement strategies, Debra G. Froberg; 4. Methodology for measuring health-State preferences - II: scaling methods, Debra G. Froberg; 5. Methodology for measuring health-State preferences - III: population and context effects, Debra G. Froberg; 5. Measurement of health state utilities for economic appraisal : a review, George W. Torrance; 7. Methods for quality adjusment of life years, Erik Nord; 8. The person-trade-off approach to valuing health care programs, Erik Nord; 9. Cost utility analysis: what should be measured?, J. Richardson; 10. Health state valuations from the general public using the visual analogue scale, C Gudex; 11. Modeling valuations for EuroQol health states, Paul Dolan; 12. Deriving preference-based single index from the UK SF-36 health survey, John Brazier; 13. Measuring preferences for health states worse than death, Donald L. Patrick; 14. Multiattribute utility function for a comprehensive health status classification system health utilities index mark 2, George W. Torrance; 15. Evaluating healthy days of life gained from health projects, Howard Barnum; 16. The utility of health at different stages in life: a quantitative approach, Jan J. V.B; 17. The economic cost of illness revisited, Barbara S. Cooper; 18. Is the valuation of a qaly gained independent of age? some empirical evidence, Magnus J; 19. Discounting in the economic evaluation of health care interventions, Murray K; 20. Maximizing health benefits vs egalitarianism: an Australian survey of health issues, Erik N; 21. Estimating the cost of illness, Dorothy P.R.; 22. Discounting in health care decision-making: time for a change ?, Trevor A. Sheldon; 23. Discounting the future: influence of the economic model, Robert R. West; 24. Penn world tables 5.6, Alan H; 25. On the comparable quantification of health risks: lessons from the global burden of disease study, Christophr J.L.M; 26. Conceptual problems in the definition and interprtation of attributable fractions, Sander G; 27. Estimability and estimation of excess and etiologic fractions, James M. Robin; 28. Reducing the global burden of blood pressure-related cardiovascular disease, Anthony R; 29. The Australian burden of disease study: measuring the loss of health from diseses, injuries and risk factors, Colin DM; 30. Mortality in relation to smoking: 40 years' observations on male British doctors, Richard D; 31. Estimated numbers of deaths from coronary heart disease "Caused" and "prevented" by alcohol: an example from Finland, Pia M; 32. Mortality from tobacco in developed countries: indirect estimation from national vital statistics, Richard P.A; 33. Intake of fatty acids and risk of coronary heart disease in a cohort of finnish men, Pirjo Pietinen; 34. Alcohol consumption and mortality among middle-aged and elderly U.S. adults, Michael J. Thun; 35. An improved aetiologic fraction of alcohol caused morbidity and mortality; 36. Dietary fat intake and the risk of coronary heart disease in women, Frank B. Hu; 37. Obesity, mortality and cardiovascular disease in the munster heart study (PROCAM), Helmut S; 38. The burden of dsease in Mexico in 1994: advances and challenges, Rafael Lozano; 39. The burden of disease and injury in Australia, Colin Mathers)
P 362.1 WOR w
[s.l.] : Geneva: WHO, 2000, s.a.]
Prosiding   Pusat Informasi Kesehatan Masyarakat
☉
cover
Workshop on evidence for health policy: burden of disease, Cost-Effectiveness, and health systems (Daftar isi: 1.Expanding the WHO tuberculosis control strategy: rethinking the role active case-finding, C.J.L. Murray; 2. Modeling the impact of global tuberculosis control strategies, ChristopherJ.L. Murray; 3. The decision rules of cost-effectiveness analysis, Goran Karlsson; 4. On the decision relus of cost-effectiveness analysis, Magnus Johannesson; 5. Cost-effectiveness and capital costs, Goran k; 6. How attractive does a new technology have to be to warrant adoption and utilization? tentative guidelines for using clinical and economic evaluations, Andreas Laupacis; 7. Methods for the economic evaluation of health care programmes, Michael F. Drummond; 8. Cost-effectiveness and cost-benefit analysis of health services: the methodology and its application, A. Griffiths; 9. Valuing health care: costs, benefits, and effectiveness of pharmaceuticals and other medical technologies, Frank A. Sloan; 10. Cost-benefit analysis (CBA); 11. Use of contingent valuation to place a monetary value on pharmacy services: an overview and review of the literature, Karen B; 12. The use of conjoint analysis to elicit willingness-to-pay values: proceed with caution?, Julie Ratcliffe; 13. Is there a role for benefit-cost analysis in environmental, health, and safety regulation ?, Kenneth J. Arrow; 14. Reasons and persons, Derek Parfit; 15. Qalys and ethics: a health economist's perspective, Alan Williams; 16. Double jeopardy and the use of QALYs in health care allocation, Peter Singer; 17. Double jeopardy, the equal value of lives and the veil of ignorance: a rejoinder to harris, John McKie; 18. The value of DALY life: problems with ethics and validity of disability adjusted life years, Erik Nord; 19. Public preferences for the allocation of donor liver grafts for transplantation, Julie Ratclife; 20. Distributing scarce livers: the moral reasoning of the general public, Peter A. Ubel; 21. Recognizing bedside rationing: clear cases and tough calls, Peter A. Ubel; 22. Estimating confidence intervals for cost-effectiveness ratios: an example from a randomized trial, Mohammad A. Chaudhary; 23. Reflecting uncertainty in cost-effectiveness analysis, W.G. Manning; 24. Hanling uncertanty in economic evaluation, Andrew Briggs; 25. Probabilistic sensitivity analysis in cost-effectiveness: an application from a study of vaccination against pneumococcal bacteremia in the elderly, William Whang; 26. Estimating uncertainty ranges for cost by the bootstrap procedure combined with probabilistic sensitivity analysis, Joanne Lord; 27. Uncertaintyin the economic evaluation of health care technologies: the role of sensitivity analysis, Andrew Briggs; 28. Building uncertainty into cost-effectiveness rankings portofolio risk-return tradeoffs and implications for decision rules, Bernie J. O'Brien; 29. Cost-effectiveness of chemotherapy for sputum smear-positive pulmonary tuberculosis in Malawi, Mozambique and Tanzania, Eric De Jonghe; 30. Linking measures of health gain to explicit priority setting by an area health service in Australia, David A Cromwell; 31. Using discrete choice modelling in priority setting: an application to clinical service developments, Shelley Farrar; 32. Cost-effectiveness analysis and policy choices: investing in health systems, C.J.L. Murray; 33. A cost-effectiveness model for allocating health sector resources, Christopher Murray; 34. Disease control priorities in developing countries: an overview, Dean T. Jamison; 35. Oregon's medicaid ranking and cost-effectiveness: is there any relationship ?, Tammy O. Tengs; 36. Five-hundred life-saving interventions and their cost-effectiveness, Tammy O. Tengs; 37. Prioritising health services in an era of limits: the Oregon experience, John A Kitzhaber; 38. Priority setting: lessons from Oregon, Jennifer Dixon; 39. Oregon's methods: did cost-effectiveness analysis fail?; 40.
P 362.1 WOR w
[s.l.] : Geneva: WHO, 2000, s.a.]
Prosiding   Pusat Informasi Kesehatan Masyarakat
☉
cover
338.43 MUE d
[s.l.] : San Fransisco: Jossey-Bass, 2002, s.a.]
Kumpulan Daftar Isi Buku   Pusat Informasi Kesehatan Masyarakat
☉
cover
Ann Bowling
613 BOW m
Buckingham : Open University Press, 2001
Buku (pinjaman 1 minggu)   Pusat Informasi Kesehatan Masyarakat
☉
:: Pengguna : Pusat Informasi Kesehatan Masyarakat
Library Automation and Digital Archive